Susquehanna International Group, LLP Pro Phase Labs, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$8.78 - $12.47 $76,386 - $108,489	8,700 Added 81.31%	19,400 $186,000
Q3 2022 Nov 14, 2022	SELL	$8.96 - $14.7 $57,344 - $94,080	-6,400 Reduced 37.43%	10,700 $121,000
Q2 2022 Aug 15, 2022	SELL	$6.52 - $13.24 $32,599 - $66,200	-5,000 Reduced 22.62%	17,100 $217,000
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $12,312 - $18,936	2,400 Added 12.18%	22,100 $158,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.82 $42,543 - $68,034	8,700 Added 79.09%	19,700 $102,000
Q2 2021 Aug 11, 2021	SELL	$4.61 - $6.83 $30,887 - $45,761	-6,700 Reduced 37.85%	11,000 $68,000
Q1 2021 May 17, 2021	BUY	$6.19 - $16.0 $109,563 - $283,200	17,700 New	17,700 $131,000

1.67M

500

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $36.4M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.